Cutler Group LLC / CA - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 119 filers reported holding DENALI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$15
-81.2%
1,700
-77.8%
0.00%
-85.7%
Q4 2022$80
-99.8%
7,650
+23.4%
0.01%
+133.3%
Q3 2022$47,000
+135.0%
6,200
+811.8%
0.00%
+200.0%
Q2 2022$20,000
-52.4%
680
-66.0%
0.00%
-50.0%
Q1 2022$42,000
-44.0%
2,000
-9.1%
0.00%
-33.3%
Q4 2021$75,000
+17.2%
2,200
-50.7%
0.00%0.0%
Q3 2021$64,000
+60.0%
4,460
+85.8%
0.00%
+50.0%
Q2 2021$40,000
+5.3%
2,400
+26.3%
0.00%0.0%
Q1 2021$38,000
-78.9%
1,900
-71.2%
0.00%
-77.8%
Q4 2020$180,000
+1900.0%
6,600
+214.3%
0.01%
+800.0%
Q3 2020$9,000
-73.5%
2,100
+45.8%
0.00%
-50.0%
Q2 2020$34,000
+6.2%
1,440
-44.6%
0.00%
+100.0%
Q1 2020$32,000
+300.0%
2,600
+420.0%
0.00%
Q4 2019$8,000
+700.0%
500
+400.0%
0.00%
Q3 2019$1,000
-50.0%
1000.0%0.00%
Q2 2019$2,0000.0%1000.0%0.00%
Q4 2018$2,0001000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders